Traditional Chinese Medicine Department, First Affiliated Hospital of Sun Yat-Sen University, Guang-zhou 510080, China.
J Tradit Chin Med. 2012 Jun;32(2):193-8. doi: 10.1016/s0254-6272(13)60010-2.
To observe the protective effects of modified Linggui Zhugan decoction combined with short-term very low calorie diets (VLCDs) on cardiovascular risk factors in obese patients with impaired glucose tolerance (IGT).
Eighty-five obese patients with IGT of spleen hypofunction and dampness accumulation type were randomly divided into treated group (n=45)and control group (n=40). The treated group was given Linggui Zhugan decoction combined short-term VLCDs. The control group was given basic weight-reduction treatment. The total course was 6 months. Changes of fasting plasma glucose (FPG), 2-hour postprandial blood glucose (2hPG), glycosylated hemoglobin (HbA1c), fasting insulin (FINS), lipid metabolism, blood pressure, body mass index (BMI) and waist circumference (WC) were observed, and the outcomes were reviewed after the treatment.
Compared with the control group, the levels of FPG, 2 hPG, HbA1c, FINS, HOMA-IR decreased significantly (P < 0.05), and the indexes of total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), systolic blood pressure (SBP), diastolic blood pressure (DBP), BMI and WC were improved significantly (P < 0.05) in the treated group. The transformation rate of normal glucose tolerance (NGT) was higher in treatment group than control group (P < 0.01). No severe adverse reaction was found in the therapeutic course.
The modified Linggui Zhugan decoction combined with short-term VLCDs has good protective effects on cardiovascular risk factors as a treatment intervention for IGT with obesity, as it could improve glycometabolism, significantly decrease the levels of blood pressure, blood lipids, BMI, WC and effectively cut-off and reverse the development of diabetes mellitus.
观察加味苓桂术甘汤联合短期极低热量饮食(VLCD)对糖调节受损(IGT)肥胖患者心血管危险因素的保护作用。
将 85 例脾肾阳虚、痰湿内盛型肥胖 IGT 患者随机分为治疗组(n=45)和对照组(n=40)。治疗组给予苓桂术甘汤联合短期 VLCD。对照组给予基础减肥治疗。总疗程 6 个月。观察空腹血糖(FPG)、餐后 2 小时血糖(2hPG)、糖化血红蛋白(HbA1c)、空腹胰岛素(FINS)、脂代谢、血压、体重指数(BMI)和腰围(WC)的变化,治疗后评价疗效。
与对照组比较,治疗组 FPG、2hPG、HbA1c、FINS、HOMA-IR 水平明显降低(P<0.05),TC、TG、LDL、SBP、DBP、BMI、WC 等指标明显改善(P<0.05)。治疗组正常糖耐量(NGT)转化率高于对照组(P<0.01)。治疗过程中未发现严重不良反应。
加味苓桂术甘汤联合短期 VLCD 对肥胖 IGT 患者的心血管危险因素具有良好的保护作用,可改善糖代谢,显著降低血压、血脂、BMI、WC 水平,有效阻断和逆转糖尿病的发生发展。